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Abstract
The neonatal mammalian heart is capable of substantial regeneration following
injury through cardiomyocyte proliferation (Porrello et al, Science 331:1078–
1080, 2011; Proc Natl Acad Sci U S A 110:187–92, 2013). However, this
regenerative capacity is lost by postnatal day 7 and the mechanisms of
cardiomyocyte cell cycle arrest remain unclear. The homeodomain transcription
factor Meis1 is required for normal cardiac development but its role in
cardiomyocytes is unknown (Paige et al, Cell 151:221–232, 2012; Wamstad
et al, Cell 151: 206–220, 2012). Here we identify Meis1 as a critical regulator of
the cardiomyocyte cell cycle. Meis1 deletion in mouse cardiomyocytes was
sufficient for extension of the postnatal proliferative window of cardiomyocytes
and for reactivation of cardiomyocyte mitosis in the adult heart with no deleteri-
ous effect on cardiac function. In contrast, overexpression of Meis1 in
cardiomyocytes decreased neonatal myocyte proliferation and inhibited neonatal
heart regeneration. Finally, we show that Meis1 is required for transcriptional
activation of the synergistic CDK inhibitors p15, p16, and p21. These results
identify Meis1 as a critical transcriptional regulator of cardiomyocyte prolifera-
tion and a potential therapeutic target for heart regeneration.
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The past decade witnessed a revolution in our understanding of cardiac biology,
with groundbreaking research demonstrating that the adult mammalian heart is
capable of limited but measurable cardiomyocyte turnover [5–9]. However, the
ultimate goal of complete regeneration of the heart remains elusive. In stark
contrast to the adult mammalian heart, we recently demonstrate that the mammalian
heart is in fact capable of complete regeneration following apical resection of 15 %
of the ventricular myocardium [1]. This remarkable regenerative capacity was
associated with robust cardiomyocyte proliferation throughout the myocardium.
Moreover, lineage-tracing studies demonstrated that the newly formed myocytes
were derived from preexisting cardiomyocytes, rather than from a progenitor
population. Finally, we showed that cessation of this regenerative phenomenon
occurred at postnatal day 7 (P7), which coincides with the developmental window
when cardiomyocytes become binucleate and withdraw from the cell cycle
[9, 10]. It is unclear whether the loss of this regenerative potential in the adult
heart is due to an intrinsic cell cycle block in adult cardiomyocytes or to loss of
mitogenic stimuli as the heart ages (or both). Thus, it is important to determine the
mechanisms by which the mammalian heart switches off this regenerative capacity
in the week after birth.
In an effort to identify genes involved in postnatal regeneration arrest, we
performed several gene arrays following MI at multiple postnatal time points.
This allowed us to identify Meis1 as one of the few transcription factors that
were dysregulated between injury at P1 and injury at P7 and P14. Meis1 has been
studied extensively in the hematopoietic system, is required for normal hematopoi-
esis, and also plays an important role in leukemogenic transformation [11–
14]. What little is known about the role of Meis1 in the heart comes from global
KO studies resulting in numerous cardiac defects. However, given that global
Meis1 deletion results in embryonic lethality by E14.5, full characterization of
the role of Meis1 in cardiomyocytes has been difficult [13, 15, 16]. Despite the role
of Meis1 in regulation of hematopoiesis and cardiac development, the mechanism
of action of Meis1 remains poorly characterized. Our results indicate that Meis1
expression and nuclear localization in cardiomyocytes coincide with cell cycle
arrest. Cardiomyocyte cell cycle exit is associated with downregulation of positive
cell cycle regulators (CDK2, CDK3, CDK4, CCND1, and CDK cofactors) and
induction of cell cycle inhibitors (CDKI, members of the INK4 and CIP/KIP
families) [10, 17–20]. We identified conserved Meis1 domains in only two key
CDK inhibitors, namely, p16 and p21, which are known to regulate all three cell
cycle checkpoints. We demonstrated that Meis1 regulates the pattern of expression
of these two cell cycle inhibitors following Meis1 knockdown. These results
provide role and mechanism of cell cycle regulation by Meis1.
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Fig. 11.1 Expression profile of Meis1 in postnatal heart. (a) qRT–PCR showing increased
expression of Meis1 at postnatal day 7 (P7), a time point that coincides with cell cycle arrest of
cardiomyocytes. (b) qRT–PCR showing expression levels of Meis1 7 days post Sham or MI at P1
or P7. (c) Expression of Meis1 is absent at P1 and nuclear localization of Meis1 in P7 and P21
cardiomyocytes
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11.2 Results
11.2.1 Expression of Meis1 During Neonatal Heart Development
and Regeneration
Transcriptional regulation of postnatal cardiomyocyte cell cycle arrest is unclear.
Our initial screens identified Meis1 as a potential transcriptional regulator of
neonatal heart regeneration. Therefore, we conducted this study to determine the
role of Meis1 in regulation of cardiomyocyte cell cycle. We first examined the
expression pattern of Meis1 during neonatal heart development and regeneration.
qPCR showed a modest increase in Meis1 expression between postnatal day
1 (P1) and P7 (Fig. 11.1a). Meis1 was localized to perinuclear regions in neonatal
cardiomyocytes at P1 and nuclear localized by P7 and P21 (Fig. 11.1c). Myocardial
infarction (MI) at P1, which is associated with an induction of robust
cardiomyocyte proliferation at day 7 post-MI, was associated with a modest
decrease in the expression of Meis1, whereas Meis1 mRNA expression levels
were significantly increased following MI at P7, a time point coinciding with lack
of mitotic induction of cardiomyocytes (Fig. 11.1b).
11.2.2 Cardiomyocyte Proliferation Beyond Postnatal Day
7 Following Meis1 Deletion
We generated cardiomyocyte-specific Meis1 knockout (KO) mice by crossing
Meis1f/f mice with αMHC-Cre mice (Fig. 11.2a). qRT–PCR of cardiomyocytes
from Meis1f/f αMHC-Cre (Meis1KO) compared to αMHC-Cre (control) mouse
hearts confirmed a change in gene expression consistent with Meis1 deletion in
cardiomyocytes (Fig. 11.2b). Phenotypic characterization of Meis1KO mice at P14
(1 week beyond the normal window of postnatal cardiomyocyte cell cycle arrest)
demonstrated that heart size (Fig. 11.2c, d) and cardiac function (Fig. 11.2e) were
unaffected by Meis1 deletion. However, Meis1KO cardiomyocytes were smaller
compared to control cardiomyocytes (Fig. 11.2f), which may imply that the
cardiomyocyte number is increased in Meis1KO (smaller cardiomyocyte size,
with no change in heart-to-body weight ratio). Therefore, we examined the
Meis1KO hearts for myocyte proliferation using the mitosis marker pH3
(phosphorylated histone H3) and the cytokinesis marker Aurora B kinase. Meis1
deletion resulted in induction of cardiomyocyte proliferation as quantified by an
increase in the number of pH3+TnnT2+ (troponin T2) cells (Fig. 11.2g). In addi-
tion, we found that Aurora B was markedly expressed in the cleavage furrow
between proliferating myocytes in the KO hearts (0.5-fold) (Fig. 11.2h). We also
found a significant increase which did not result in an increase in myocyte apoptosis
by TdT-mediated dUTP nick end labeling (TUNEL) staining (Fig. 11.2k).
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11.2.3 MI in Meis1 Overexpressing Heart Limits Neonatal Heart
Regeneration
To determine whether forced Meis1 expression can inhibit neonatal cardiomyocyte
proliferation, we generated a cardiac-specific Meis1 overexpressing mouse (Meis1
OE) by crossing pTRE-Meis1 mice with αMHC-tTA mice to allow for specific
overexpression of Meis1 in cardiomyocytes (Fig. 11.3a) around birth in the absence
of tetracycline. We used a Meis1 line that overexpressed Meis1 by 2.5-fold
(Fig. 11.3b). Overexpression of Meis1 did not result in a significant increase in
heart-to-body weight ratio (Fig. 11.3c, d), normal systolic function (Fig. 11.3e), and
increased cardiomyocyte size (Fig. 11.3f). Despite the increase in cardiomyocyte
size in Meis1 (OE) hearts, the lack of decrease in heart-to-body weight ratio most
probably reflects a decrease in the number of cardiomyocytes. This is supported by
a decrease in the number of mitotic cardiomyocytes in the neonatal Meis1
(OE) hearts (Fig. 11.3g). More notably, Meis1 OE inhibited neonatal heart regen-
eration following induction of MI at P1 (Fig. 11.3h–j), whereas the wild-type hearts
regenerated normally. Finally, Meis1 OE in cardiomyocytes resulted in
upregulation of CDK inhibitors, most significantly p21 (Cdkn1a) (Fig. 11.3k).
These results indicate that Meis1 overexpression in the neonatal heart results in
premature cardiomyocyte cell cycle arrest.
Fig. 11.2 Cardiomyocyte proliferation at P14 following Meis1 deletion. (a) Schematic of Meis1
floxed allele. Control mice were αMHC-Cre, Meis1KO mice were Meis1f/fαMHC-Cre. (b) qRT–
PCR demonstrates deletion of Meis1 in cardiomyocytes at P14. (c) Trichrome staining of wild-
type (WT) and Meis1KO hearts at P14. (d) Heart weight (HW)-to-body weight (BW) ratio in WT
and Meis1KO hearts. (e) Left ventricular (LV) systolic function quantified by ejection fraction
(EF) and fractional shortening (FS). (f) Wheat germ agglutinin (WGA) staining and cell size
quantification. (g) Confocal image with z-stacking showing co-localization of pH3, TnnT2, and
Hoechst in a Meis1KO heart at P14. Immunostaining showing sarcomere disassembly and normal
sarcomeric structure in Meis1KO hearts. Graph shows quantification of the number of
pH31+TnnT21+ nuclei. (h) Expression of Aurora B in Meis1KO cardiomyocytes at P14 and
quantification of the number of Aurora B+TnnT2+ cardiomyocytes
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11.2.4 Regulation of Cyclin-Dependent Kinase Inhibitors by Meis1
In order to determine the mechanism by which Meis1 regulates cardiomyocyte
proliferation, we performed a cell cycle PCR array. We found that Meis1 deletion
resulted in downregulation of cyclin-dependent kinase inhibitors in isolated
cardiomyocytes, including members of the Ink4b–Arf–Ink4a locus (p16, p15, and
p19ARF) and CIP/ KIP family (p21 and p57), as well as upregulation of a number
of positive regulators of the cell cycle (Fig. 11.3a, b). qRT–PCR confirmed these
results (Fig. 11.4a). Of all the dysregulated cell cycle genes, we identified
conserved Meis1 consensus binding sequences in the promoter region of only two
loci, namely, the Ink4b–Arf–Ink4a (which includes p16INK4a, p19ARF, and
p15INK4b) (Fig. 11.4b) and p21 loci (Fig. 11.4c) using the UCSC genome browser
(http://genome.ucsc.edu). To test if Meis1 can transcriptionally activate Ink4b–
Fig. 11.3 Meis1 overexpression limits neonatal heart regeneration following MI. (a) Schematic
of Meis1 overexpression (OE) in the heart. Control mice were αMHC-tTA, Meis1 (OE) mice were
pTREMeis1-αMHC-tTA. (b) qRT–PCR demonstrates overexpression of Meis1. (c) HW-to-BW
ratio in control and Meis1 (OE) mice. (d) H & E staining of WT and Meis1 (OE) hearts. (e) LV
systolic function quantified by EF. (f) WGA staining and cell size quantification. (g)
Immunostaining image showing co-localization of pH3, TnnT2, and Hoechst in Meis1
(OE) heart at P3. Graph shows quantification of pH3+TnnT2+ nuclei. (h) Schematic of neonatal
MI during the regenerative window at P1. (i) LV systolic function of WT and Meis1 (OE) hearts at
21 days post-MI. (j) Trichromes at day 21 post-MI. (k) qRT–PCR of CDKIs in hearts of Meis1
(OE) compared to control
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Arf–Ink4a and p21, we generated luciferase reporter constructs containing the
conserved Meis1 binding motifs. Luciferase reporter assays with INK4b–ARF–
INK4a–pGL2 (Fig. 11.4b) and p21–pGL2 reporters (Fig. 11.4c) demonstrated a
dose-dependent activation by Meis1. Mutation of the putative Meis1 binding sites
abolished the Meis1-dependent activation of the luciferase reporters (Fig. 11.4b, c).
Finally, we demonstrated an in vivo interaction between Meis1 and Ink4b–Arf–
Ink4a and p21 promoters in the adult mouse heart by ChIP (Figs. 11.4d and 11.5).
11.3 Future Direction and Clinical Implications
The current study identifies Meis1 as a critical transcriptional regulator of
cardiomyocyte cell cycle, upstream of two synergistic CDKI inhibitors. Although
the mechanism of activation of Meis1 in the postnatal heart is not quite fully
understood, results have demonstrated that Meis1 expression coincides with Hox
genes that are known to interact with Meis1, stabilize its DNA binding, and enhance
its transcriptional activity. Therefore, it would be important for future studies to
define the transcriptional network involved in mediating the effect of Meis1 on
postnatal cardiomyocytes. Ultimately, we hope to utilize our understanding of the
role and mechanism of Meis1 in cardiomyocyte proliferation to uncover new
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Fig. 11.4 Regulation of cyclin-dependent kinase inhibitors by Meis1. (a) qPCR of CDKIs in
purified Meis1KO cardiomyocytes demonstrates significant downregulation of CDKN1A (p21),
CDKN2B (p15), CDKN2A (p16), p19ARF, CDKN2C (p18), and CDKN1C (p57). (b) Highly
conserved Meis1 motifs located in p16INK4a/p19ARF/p15INK4b promoter and luciferase
reporter assay for INK4b–ARF–INK4a promoter demonstrating induction of INK4b–ARF–
INK4a pGL2 reporter by Meis1 and loss of reporter activity following mutation of Meis1 motifs
(INK4b–ARF–INK4a-Mutant). (c) Highly conserved Meis1 motif located in p21 promoter and
luciferase assay for p21 demonstrating induction of p21 pGL2 reporter by Meis1 and loss of
reporter activity following mutation of Meis1 motifs (p21 Mutant). (d) In vivo confirmation of
Meis1 interaction with INK4a/ARF/INK4b and p21 promoters by ChIP assay
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